Skip to main content

Competing Risks, Treatment Switching, and Informative Censoring.

Publication ,  Journal Article
Thomas, LE; Turakhia, MP; Pencina, MJ
Published in: JAMA Cardiol
August 1, 2021

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

JAMA Cardiol

DOI

EISSN

2380-6591

Publication Date

August 1, 2021

Volume

6

Issue

8

Start / End Page

871 / 873

Location

United States

Related Subject Headings

  • Treatment Switching
  • Risk Assessment
  • Models, Statistical
  • Humans
  • 3201 Cardiovascular medicine and haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Thomas, L. E., Turakhia, M. P., & Pencina, M. J. (2021). Competing Risks, Treatment Switching, and Informative Censoring. JAMA Cardiol, 6(8), 871–873. https://doi.org/10.1001/jamacardio.2021.1239
Thomas, Laine Elliott, Mintu P. Turakhia, and Michael J. Pencina. “Competing Risks, Treatment Switching, and Informative Censoring.JAMA Cardiol 6, no. 8 (August 1, 2021): 871–73. https://doi.org/10.1001/jamacardio.2021.1239.
Thomas LE, Turakhia MP, Pencina MJ. Competing Risks, Treatment Switching, and Informative Censoring. JAMA Cardiol. 2021 Aug 1;6(8):871–3.
Thomas, Laine Elliott, et al. “Competing Risks, Treatment Switching, and Informative Censoring.JAMA Cardiol, vol. 6, no. 8, Aug. 2021, pp. 871–73. Pubmed, doi:10.1001/jamacardio.2021.1239.
Thomas LE, Turakhia MP, Pencina MJ. Competing Risks, Treatment Switching, and Informative Censoring. JAMA Cardiol. 2021 Aug 1;6(8):871–873.

Published In

JAMA Cardiol

DOI

EISSN

2380-6591

Publication Date

August 1, 2021

Volume

6

Issue

8

Start / End Page

871 / 873

Location

United States

Related Subject Headings

  • Treatment Switching
  • Risk Assessment
  • Models, Statistical
  • Humans
  • 3201 Cardiovascular medicine and haematology